all - Opinion Summaries

  FILL IN AT LEAST ONE FIELD    
Court: Docket Number:
Legal Topic: Party Name:
Industry: Date:


Format YYYYMM
Date Range: to Format is YYYYMMDD
Enter Keywords or text:
Description Date Docket #
Xitronix Corp. v. KLA-Tencor Corp.
United States Fifth Circuit
Antitrust & Trade Regulation, Patent
The Fifth Circuit transferred a case back to the Federal Circuit, from which it had been transferred. The two circuits disagreed about which one was...
02/15/2019 18-50114
ABS Global, Inc. v. Inguran, LLC
United States Seventh Circuit
Agriculture, Antitrust & Trade Regulation, Patent
In a dispute between two companies in the agriculture-related biotechnology field, affirmed in part and reversed in part a judgment after a jury...
01/29/2019 17‐1873
Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc.
United States Supreme Court
Intellectual Property, Drugs & Biotech, Patent
Held that an inventor's sale of an invention to a third party who is obligated to keep the invention confidential can qualify as prior art for...
01/22/2019 17–1229
Soarus LLC v. Bolson Materials International Corp.
United States Seventh Circuit
Contracts, Trade Secrets, Patent
Held that a company did not violate a nondisclosure agreement by including particular information in a patent application for a 3D printing process....
10/01/2018 18-1144
ParkerVision, Inc. v. Qualcomm Inc.
United States Federal Circuit
Intellectual Property, Patent
Affirmed that some, but not all, claims in a telecommunications patent were unpatentable as obvious. Finding no error, the Federal Circuit affirmed...
09/13/2018 17-2012
Nobel Biocare Services AG v. Instradent USA, Inc.
United States Federal Circuit
Intellectual Property, Patent
A company appealed from the determination in an inter partes review that certain claims of its patent directed to dental implants were unpatentable....
09/13/2018 17-2256
Orexo AB v. Actavis Elizabeth LLC
United States Federal Circuit
Intellectual Property, Patent
Reversed a judgment that a patent for a pharmaceutical product was invalid on the ground of obviousness. The Federal Circuit concluded that...
09/10/2018 17-1333
Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc.
United States Federal Circuit
Intellectual Property, Patent
Affirmed that a pharmaceutical company's patent claims in a multiple sclerosis drug were invalid for obviousness. Several competitors seeking to...
09/10/2018 17-2078
IXI IP, LLC v. Samsung Electronics Co., Ltd.
United States Federal Circuit
Intellectual Property, Patent
Affirmed that certain patent claims relating to a wireless networking device were invalid as obvious. The Federal Circuit affirmed the Patent Trial...
09/10/2018 17-1665
University of California v. Broad Institute, Inc.
United States Federal Circuit
Patent, Intellectual Property, Drugs & Biotech
Affirmed a judgment of no interference-in-fact in a patent case involving the CRISPR-Cas9 system for the targeted cutting of DNA molecules. The...
09/10/2018 17-1907

FindLaw Career Center

    Select a Job Title


      Post a Job  |  Careers Home

    View More